Search results
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update
FOX21 Colorado Springs· 2 days agoDelivered solid performance to start 2024, with record-breaking first quarter revenue of 34.1 billion KRW. Phase 3 VELOS-4 study of tanfanercept in dry eye disease expected ...
Antigenic Characterization of Novel Human Norovirus GII.4 Variants San Francisco 2017 and Hong Kong...
Centers for Disease Control and Prevention· 6 days agoNovel Human Norovirus GII.4 Variants
Epidemiologic Survey of Crimean-Congo Hemorrhagic Fever Virus in Suids, Spain
Centers for Disease Control and Prevention· 6 days agoCrimean-Congo hemorrhagic fever virus (CCHFV; genus Orthonairovirus family Nairoviridae) is an emerging pathogen mainly transmitted by ticks of the genus Hyalomma (1,2). This arbovirus is the ...
Earnings call: Bio-Techne sees growth in Q3 with strong market positioning
Investing.com· 7 hours agoThe company's Diagnostics and Genomics segment showed a robust 10% organic growth, while the Protein...
A Better Concept For mRNA Vaccines: Self-Amplification
Forbes· 3 days agoTwo new self-amplifying mRNA vaccines herald a new era of vaccination for coronaviruses.
Taking the bite out of snake venom
Phys.org· 3 days agoEvery year around 5.4 million people globally—often in the world's poorest communities—are bitten by venomous snakes, with countries such as Bangladesh,...
Wife on a mission: Polk woman refuses to 'wait-and-see' on husband's kidney transplant
The Ledger via Yahoo News· 3 days agoThe most common method of checking for PKD is an ultrasound, a test that uses sound waves to form...
Statement on the antigen composition of COVID-19 vaccines
World Health Organization· 6 days agoApril 2024 statement on the antigen composition of COVID-19 vaccines
Man receives world’s first melanoma vaccine — trial underway
NY Post via Yahoo News· 6 days agoScans showed I was radiologically clear, obviously there is still the chance I had cancer cells...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure
Investor's Business Daily· 6 days agoLenmeldy won its U.S. approval last month for a rare genetic condition and goes for $4.25 million a...